December 2014 Newsletter

As we approach the end of the year, I am very proud to share with you that this year has been a very successful year for IASLC!
Our meetings, both regional meetings and smaller meetings/workshops, have been very successful in terms of science and attendance. For the next year we will have the World Conference in September; we will continue our more “traditional” smaller meetings; we will also expand the focused meetings, which will include an expert meeting on Small Cell Lung Cancer in April in New York City, and we will also plan for a specific immunotherapy meeting in the fall of 2015.

The International Association for the Study of Lung Cancer mourns the loss of Dr. Nigel Gray. Dr. Gray was the pioneer behind Australia’s tobacco control. The former Cancer Council Victoria director is remembered as being a “fearless” opponent of the tobacco industry. He was a member of IASLC for 21 years and his presence will be missed.

November Member Newsletter

Over the last month IASLC had two successful events; the ASTRO/ASCO/IASLC Multidisciplinary Meeting in Chicago, which had about 800 participants and the Asian Pacific Lung Cancer Meeting (APLCC) in Kuala Lumpur with about the same number of participants. Kudos to Dr. Karen Kelly chairing the Chicago meeting and to Drs. Liam and Ibrahim chairing the APLCC meeting in KL. IASLC will continue to grow the regional meetings, which is an important mission of our organization.

DENVER – November is Lung Cancer Awareness Month and the International Association for the Study of Lung Cancer (IASLC) is the only global organization solely dedicated to the study of lung cancer and is committed to conquer thoracic malignancies worldwide. Lung cancer is a devastating disease with 1.6 million people diagnosed globally (US 225,000) each year which results in 1.4 million deaths (US 160,000). Lung cancer is the leading cause of cancer-related deaths in both men and women throughout the world.

Participants at the 2014 IASLC Asia Pacific Lung Cancer Conference pass resolution on tobacco control.

Personalized medicine, treating the patient with therapies that are predicted to be effective based on the molecular characteristics of the tumor, can add years of life for those patients whose tumor harbor specific abnormalities and treated with a therapy specifically targeting this abnormality